Earnings Call Summary | Blade Air Mobility(BLDE.US) Q1 2024 Earnings Conference
Earnings Call Summary | Blade Air Mobility(BLDE.US) Q1 2024 Earnings Conference
The following is a summary of the Blade Air Mobility, Inc. (BLDE) Q1 2024 Earnings Call Transcript:
以下是Blade Air Mobility, Inc.（BLDE）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Blade Air reported a 13.8% increase in Q1 2024 revenue amounting to $51.5 million compared to the same period in 2023.
Excluding the discontinued Blade 1, revenue increased by 21.5% year-on-year.
The company reported a significant 41.5% year-on-year increase in total flight profit.
Medical revenues increased by 34.6% in Q1 2024.
Adjusted EBITDA improved by $4.2 million in Q1 2024 compared to Q1 2023.
Blade had $151 million in cash and short-term investments at the end of Q1 2024.
Blade Air報告稱，與2023年同期相比，2024年第一季度收入增長了13.8％，達到5150萬美元。
不包括已停產的Blade 1，收入同比增長21.5％。
該公司報告稱，航班總利潤同比大幅增長41.5％。
2024年第一季度，醫療收入增長了34.6％。
與2023年第一季度相比，2024年第一季度調整後的息稅折舊攤銷前利潤增加了420萬美元。
截至2024年第一季度末，Blade擁有1.51億美元的現金和短期投資。
Business Progress:
業務進展：
A strong start in 2024 in its medical business marked by record revenues, growth driven by increased trip volumes and distances.
Profitability improvement across the business, including cost rationalization measures and the discontinuation of Blade 1.
Blade anticipates further profitability improvement in passenger business and plans to manage corporate cost.
Seth Bacon, founder of Trinity Air Medical, will be the Executive Chairman of Blade Medical and Scott Wunsch, the existing medical COO, will become the CEO of Blade Medical.
They are expanding their medical sector strategy into moving other critical cargo beyond patients and organs.
The company has a pipeline for new customer acquisition and continues to evaluate growth opportunities, including a potential expansion into other critical cargo and ground transportation markets.
Speculation for transitions to electric vertical aircraft (EVA) possibly in 2026 or 2027.
2024年，其醫療業務開局良好，收入創歷史新高，出行量和距離的增加推動了增長。
整個業務的盈利能力提高，包括成本合理化措施和Blade 1的停產。
Blade預計客運業務的盈利能力將進一步提高，並計劃管理公司成本。
Trinity Air Medical的創始人塞思·培根將擔任Blade Medical的執行董事長，現任醫療首席運營官斯科特·溫施將出任Blade Medical的首席執行官。
他們正在擴大其醫療部門戰略，將其他關鍵貨物運送到患者和器官以外的領域。
該公司有機會獲得新客戶，並將繼續評估增長機會，包括向其他關鍵貨運和地面運輸市場的潛在擴張。
有人猜測可能在2026年或2027年過渡到電動垂直飛機（EVA）。
More details: Blade Air Mobility IR
更多詳情： 刀鋒空中機動紅外
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。